Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens

Psychopharmacology

Volumn 233, Issue 8, 2016, Pages 1405-1413

  Hong, Sa Ik ^a   Kim, Min Jung ^a   You, In Jee ^a   Kwon, Seung Hwan ^a   Ma, Shi Xun ^a   Hwang, Ji Young ^a   Seo, Jee Yeon ^a   Ko, Yong Hyun ^a   Lee, Bo Ram ^a   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Accumbens; Dopamine transporter; Reward

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; APOMORPHINE; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; PHENTERMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; ANTIOBESITY AGENT; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CLIMBING; CLIMBING BEHAVIOR TEST; CONDITIONED PLACE PREFERENCE TEST; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG SEEKING BEHAVIOR; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGIC TEST; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; REWARD;

ANIMALS; ANTI-OBESITY AGENTS; APOMORPHINE; CONDITIONING (PSYCHOLOGY); DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; MICE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; ONCOGENE PROTEIN V-AKT; PHENTERMINE; PHOSPHATIDYLINOSITOL 3-KINASES; REWARD; SIGNAL TRANSDUCTION;

EID: 84958761025     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-016-4231-z     Document Type: Article

References (44)

1. Beaulieu JM (2012) A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci 37:7-16
2. Beaulieu JM, Gainetdinov RR, Caron MG (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49:327-347
3. Blakely RD, Defelice LJ, Galli A (2005) Biogenic amine neurotransmitter transporters: just when you thought you knew them. Physiology (Bethesda) 20:225-231
4. Braren SH, Drapala D, Tulloch IK, Serrano PA (2014) Methamphetamine-induced short-term increase and long-term decrease in spatial working memory affects protein Kinase M zeta (PKMzeta), dopamine, and glutamate receptors. Front Behav Neurosci 8:438
5. Carvelli L, Moron JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lundberg LM, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A (2002) PI 3-kinase regulation of dopamine uptake. J Neurochem 81:859-869
6. Cha HJ, Lee HA, Ahn JI, Jeon SH, Kim EJ, Jeong HS (2013) Dependence potential of quetiapine: behavioral pharmacology in rodents. Biomol Ther (Seoul) 21:307-312
7. Cha HJ, Song MJ, Lee KW, Kim EJ, Kim YH, Lee Y, Seong WK, Hong SI, Jang CG, Yoo HS, Jeong HS (2014) Dependence potential of tramadol: behavioral pharmacology in rodents. Biomol Ther (Seoul) 22:558-562
8. Chauhan H, Killinger BA, Miller CV, Moszczynska A (2014) Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum. Int J Mol Sci 15:5884-5906
9. Choi CS, Hong M, Kim KC, Kim JW, Yang SM, Seung H, Ko MJ, Choi DH, You JS, Shin CY, Bahn GH (2014) Effects of atomoxetine on hyper-locomotive activity of the prenatally valproate-exposed rat offspring. Biomol Ther (Seoul) 22:406-413
10. Cui Y, Zhang XQ, Xin WJ, Jing J, Liu XG (2010) Activation of phosphatidylinositol 3-kinase/Akt-mammalian target of Rapamycin signaling pathway in the hippocampus is essential for the acquisition of morphine-induced place preference in rats. Neuroscience 171:134-143
11. Figlewicz DP, Szot P, Chavez M, Woods SC, Veith RC (1994) Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res 644:331-334
12. Galici R, Galli A, Jones DJ, Sanchez TA, Saunders C, Frazer A, Gould GG, Lin RZ, France CP (2003) Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 77:132-140
13. Garcia BG, Wei Y, Moron JA, Lin RZ, Javitch JA, Galli A (2005) Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 68:102-109
14. Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A (2009) Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cell Signal 21:87-94
15. Go RE, Hwang KA, Kim SH, Lee MY, Kim CW, Jeon SY, Kim YB, Choi KC (2014) Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model. Lab Anim Res 30:73-78
16. Gruner JA, Marcy VR, Lin YG, Bozyczko-Coyne D, Marino MJ, Gasior M (2009) The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents. Sleep 32:1425-1438
17. Hainer V (2010) Drug treatment of obesity - current situation and perspectives. Cas Lek Cesk 149:513-519
18. Hensleigh E, Pritchard LM (2014) The effect of early environmental manipulation on locomotor sensitivity and methamphetamine conditioned place preference reward. Behav Brain Res 268:66-71
19. Izzo E, Martin-Fardon R, Koob GF, Weiss F, Sanna PP (2002) Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nat Neurosci 5:1263-1264
20. John CE, Jones SR (2007) Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52:1596-1605
21. Koob GF, Volkow ND (2009) Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238
22. Lee SY, You IJ, Kim MJ, Kwon SH, Hong SI, Kim JH, Jang MH, Oh SM, Chung KH, Jang CG (2013) The abuse potential of oxethazaine: effects of oxethazaine on drug-seeking behavior and analysis of its metabolites in plasma and hair in animal models. Pharmacol Biochem Behav 105:98-104
23. Lute BJ, Khoshbouei H, Saunders C, Sen N, Lin RZ, Javitch JA, Galli A (2008) PI3K signaling supports amphetamine-induced dopamine efflux. Biochem Biophys Res Commun 372:656-661
24. Lv T, Wang SD, Bai J (2013) Thioredoxin-1 was required for CREB activity by methamphetamine in rat pheochromocytoma cells. Cell Mol Neurobiol 33:319-325
25. Manzanares J, Canton R, Grande C, Benedi J, Zaragoza F (1988) Amphetamine and chlorpromazine modify cerebral insulin levels in rats. Life Sci 42:21-25
26. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 18:8417-8422
27. Mines MA, Jope RS (2012) Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice. Cell Signal 24:1398-1405
28. Morton GJ, Gelling RW, Niswender KD, Morrison CD, Rhodes CJ, Schwartz MW (2005) Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons. Cell Metab 2:411-420
29. Nelson DL, Gehlert DR (2006) Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 29:49-60
30. Oyemitan IA, Olayera OA, Alabi A, Abass LA, Elusiyan CA, Oyedeji AO, Akanmu MA (2015) Psychoneuropharmacological activities and chemical composition of essential oil of fresh fruits of Piper guineense (Piperaceae) in mice. J Ethnopharmacol
31. Paxinos GFKTMBS, Coordinates CneEAP, Boston A (2004) The Mouse Brain in Stereotaxic Coordinates, Compact. Elsevier Academic Press, Amsterdam; Boston
32. Pogorelov VM, Nomura J, Kim J, Kannan G, Ayhan Y, Yang C, Taniguchi Y, Abazyan B, Valentine H, Krasnova IN, Kamiya A, Cadet JL, Wong DF, Pletnikov MV (2012) Mutant DISC1 affects methamphetamine-induced sensitization and conditioned place preference: a comorbidity model. Neuropharmacology 62:1242-1251
33. Protais P, Costentin J, Schwartz JC (1976) Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology (Berl) 50:1-6
34. Rea WP, Rothman RB, Shippenberg TS (1998) Evaluation of the conditioned reinforcing effects of phentermine and fenfluramine in the rat: concordance with clinical studies. Synapse 30:107-111
35. Robertson SD, Matthies HJ, Owens WA, Sathananthan V, Christianson NS, Kennedy JP, Lindsley CW, Daws LC, Galli A (2010) Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci 30:11305-11316
36. Rothman RB, Elmer GI, Shippenberg TS, Rea W, Baumann MH (1998) Phentermine and fenfluramine. Preclinical studies in animal models of cocaine addiction. Ann N Y Acad Sci 844:59-74
37. Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, Winstanley CA, Renthal NE, Wiley MD, Self DW, Russell DS, Neve RL, Eisch AJ, Nestler EJ (2007) IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10:93-99
38. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, Trixler M, Maier W, Wildenauer DB (2005) Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 58:446-450
39. Schwendt M, Rocha A, See RE, Pacchioni AM, McGinty JF, Kalivas PW (2009) Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther 331:555-562
40. Shah A, Silverstein PS, Singh DP, Kumar A (2012) Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-kappaB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes. J Neuroinflammation 9:52
41. Skopp G, Jantos R (2013) Phentermine - a "weighty" or a dangerous substance? Arch Kriminol 231:116-129
42. Speed N, Saunders C, Davis AR, Owens WA, Matthies HJ, Saadat S, Kennedy JP, Vaughan RA, Neve RL, Lindsley CW, Russo SJ, Daws LC, Niswender KD, Galli A (2011) Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PLoS ONE 6, e25169
43. Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406-433
44. Wei Y, Williams JM, Dipace C, Sung U, Javitch JA, Galli A, Saunders C (2007) Dopamine transporter activity mediates amphetamine-induced inhibition of Akt through a Ca2+/calmodulin-dependent kinase II-dependent mechanism. Mol Pharmacol 71:835-842